| Christina Marie Macgowan, RPH | |
|
1701 Jackson St, Golden, CO 80401-1925 | |
| (303) 278-2284 | |
| Not Available |
| Full Name | Christina Marie Macgowan |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 1701 Jackson St, Golden, Colorado |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1568608115 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 13009 (Colorado) | Primary |
| 183500000X | Pharmacist | 43720 (California) | Secondary |
| Mailing Address | Practice Location Address |
|---|---|
| Christina Marie Macgowan, RPH 1701 Jackson St, Golden, CO 80401-1925 Ph: (303) 278-2284 | Christina Marie Macgowan, RPH 1701 Jackson St, Golden, CO 80401-1925 Ph: (303) 278-2284 |
News Archive
Researchers have taken a first snapshot of how a class of highly reactive molecules inflicts cellular damage as part of aging, heart disease, stroke, cancer, diabetes, kidney disease and Alzheimer's disease to name a few. According to a study published today in the journal Cell, researchers have discovered a tool that can monitor related damage and determine the degree to which antioxidant drugs effectively combat disease.
A team of scientists from India has recently investigated the antiviral potency of a traditional medicinal plant Cissampelos pareira L. in preventing severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. The findings reveal that both whole-plant extracts and bioactive compounds can inhibit SARS-CoV-2 replication by modulating estrogen receptor 1 (ESR1) activity.
It is not surprising that as our economy continues its freefall, we are feeling increasingly more stressed and worried.
Ligand Pharmaceuticals Incorporated today announced that data from a Phase I study with its selective androgen receptor modulator (SARM) LGD-4033 was featured today in a poster presentation at the 14th International Congress of Endocrinology in Kyoto, Japan. This Phase I clinical trial was the first study in humans of LGD-4033, and evaluated the safety, tolerability and pharmacokinetic profiles of the molecule in a single escalating dose, double blind, placebo-controlled study in 48 healthy volunteers.
In the event of an outbreak or a bioterrorist attack, rapid identification of the genetic changes responsible for virulence or drug resistance is essential to mounting an effective response.
› Verified 3 days ago
Ashley Toombs, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1707 Cole Blvd Ste 100, Golden, CO 80401 Phone: 720-530-3440 | |
Brian T Le, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 17171 S Golden Rd, Golden, CO 80401 Phone: 303-279-5684 Fax: 303-279-5898 | |
James Aldridge, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1286 Wyoming St, Golden, CO 80403 Phone: 303-720-1021 | |
Gregory John Sabatos, RPH. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 607 Somerset Dr, Golden, CO 80401 Phone: 720-840-4466 | |
Dr. Sarah Carman Rivas, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 780 Simms St Ste 103, Golden, CO 80401 Phone: 303-237-4478 Fax: 303-237-4478 | |
Dr. Theresa Cao, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 15000 W 6th Ave, Golden, CO 80401 Phone: 303-495-8543 | |
Marina Serdyuk, PHARM D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1707 Cole Blvd Ste 100, Golden, CO 80401 Phone: 720-201-3731 |